These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2828894)

  • 21. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa.
    Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Pier GB; Puckett JM; Sewell TJ; Sigal NH
    Infect Immun; 1988 May; 56(5):1209-14. PubMed ID: 3128480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.
    Stoll BJ; Pollack M; Young LS; Koles N; Gascon R; Pier GB
    Infect Immun; 1986 Sep; 53(3):656-62. PubMed ID: 2427453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.
    Warrener P; Varkey R; Bonnell JC; DiGiandomenico A; Camara M; Cook K; Peng L; Zha J; Chowdury P; Sellman B; Stover CK
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4384-91. PubMed ID: 24841258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa.
    Sawada S; Kawamura T; Masuho Y
    J Gen Microbiol; 1987 Dec; 133(12):3581-90. PubMed ID: 3141560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
    Sawada S; Kawamura T; Masuho Y; Tomibe K
    J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.
    Secher T; Fauconnier L; Szade A; Rutschi O; Fas SC; Ryffel B; Rudolf MP
    J Antimicrob Chemother; 2011 May; 66(5):1100-9. PubMed ID: 21393169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of mouse monoclonal antibodies produced by immunisation with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccine.
    Barclay GR; Yap PL; McClelland DB; Jones RJ; Roe EA; McCann MC; Micklem LR; James K
    J Med Microbiol; 1986 Feb; 21(1):87-90. PubMed ID: 3081727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
    J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model.
    Patel A; DiGiandomenico A; Keller AE; Smith TRF; Park DH; Ramos S; Schultheis K; Elliott STC; Mendoza J; Broderick KE; Wise MC; Yan J; Jiang J; Flingai S; Khan AS; Muthumani K; Humeau L; Cheng LI; Wachter-Rosati L; Stover CK; Sardesai NY; Weiner DB
    Nat Commun; 2017 Sep; 8(1):637. PubMed ID: 28935938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-glycolipid antibodies produced by Epstein-Barr virus (EBV)-transformed oligoclonal B cell lines obtained from normal persons and autoimmune disease patients.
    Nagatsuka Y; Hanazawa S; Yasuda T; Ono Y
    Hum Antibodies Hybridomas; 1994; 5(3-4):183-6. PubMed ID: 7756582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa.
    Markham RB; Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S957-62. PubMed ID: 6419317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-bacterial antibodies in Epstein-Barr virus (EBV)-transformed oligoclonal B-cell lines established from normal persons and autoimmune disease patients.
    Nagatsuka Y; Hanazawa S; Koroiwa Y; Fukuda T; Suganuma T; Ono Y
    Lett Appl Microbiol; 1994 Oct; 19(4):206-9. PubMed ID: 7765395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
    Fisher MW
    J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Pseudomonas immunoglobulin I. Immunization of sheep.
    Schiller B; Buchowicz I; Korbecki M; Lysakowska E; Rudnicka W; Robaczewska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):627-33. PubMed ID: 6812540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia.
    Zweerink HJ; Detolla LJ; Gammon MC; Hutchison CF; Puckett JM; Sigal NH
    J Infect Dis; 1990 Jul; 162(1):254-7. PubMed ID: 2113078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of molecular biology on Pseudomonas aeruginosa immunization.
    Pennington JE
    J Hosp Infect; 1988 Feb; 11 Suppl A():96-102. PubMed ID: 2896754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.